Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
500
datasets available to search
ShareScore release 0.9.0
Dataset results
500 results for “Mastectomy”
Post Mastectomy Shoulder Problems and Kinesio Taping
ClinicalTrials.gov study NCT02749539. IPD Sharing: YES. Countries: 0. Publications: 0.
Erector Spinae Plane Block Versus Paravertebral Block in Mastectomy
ClinicalTrials.gov study NCT03490006. IPD Sharing: NO. Countries: 0. Publications: 0.
Oncologic Outcomes of Minimal Access Nipple-sparing Mastectomy Compared With Conventional Approach in Breast Cancer
ClinicalTrials.gov study NCT07069803. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Effects of Ultrasound-Guided Stellate Ganglion Block and Transcutaneous Auricular Vagus Nerve Stimulation on Sleep Quality After Radical Mastectomy for Breast Cancer
ClinicalTrials.gov study NCT07272954. IPD Sharing: YES. Countries: 0. Publications: 0.
Self-Affirmation Intervention After Mastectomy
ClinicalTrials.gov study NCT07355244. IPD Sharing: NO. Countries: 0. Publications: 0.
Effect of Endorphin Massage on Surgical Fear, Anxiety and Pain Before Mastectomy
ClinicalTrials.gov study NCT06755983. IPD Sharing: NO. Countries: 0. Publications: 0.
Emotional Security and Quality of Life Among Breast Cancer Patient Who Have Undergo Mastectomy
ClinicalTrials.gov study NCT04872803. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Comparative Study of Ketamine Added to Bupivacaine in PECS Block Versus Topical Wound Instillation on Post Operative Analgesia in Modified Radical Mastectomy Surgery
ClinicalTrials.gov study NCT05410158. IPD Sharing: Not stated. Countries: 0. Publications: 0.
SurgiMend in Two-stage Implant-based Breast Reconstruction in Patients With Pre-Mastectomy Radiotherapy
ClinicalTrials.gov study NCT01959867. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and Mastectomy
ClinicalTrials.gov study NCT05993559. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Myofascial Release or Trigger Point Injections for the Reduction of Post-Mastectomy Pain Syndrome
ClinicalTrials.gov study NCT05041751. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Targeted Nerve Surgery for the Prevention of Post-Mastectomy Pain Syndrome: A Randomized Trial
ClinicalTrials.gov study NCT07146009. IPD Sharing: NO. Countries: 0. Publications: 0.
Study to Evaluate a Preop Dose of Brivoligide Injection for Pain After Mastectomy in Patients With High PCS Scores
ClinicalTrials.gov study NCT04104919. IPD Sharing: NO. Countries: 0. Publications: 0.
Stellate Ganglionic Block Versus Stellate Ganglionic Block Plus Pecs II Block for Mastectomy Pain
ClinicalTrials.gov study NCT02641951. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
The Effect of Preoperative Education on Postoperative Healing Quality in Patients With Mastectomy
ClinicalTrials.gov study NCT05914415. IPD Sharing: NO. Countries: 0. Publications: 0.
Arnica Montana and Bellis Perennis for Prevention of Seroma After Mastectomy
ClinicalTrials.gov study NCT03512639. IPD Sharing: NO. Countries: 0. Publications: 0.
Effects of Regional Anesthesia Following Mastectomy
ClinicalTrials.gov study NCT05276440. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Evaluation of a Breast Biblock Analgesia for the Mastectomy With Radical Axillary Lymphadenectomy Surgery
ClinicalTrials.gov study NCT02963857. IPD Sharing: NO. Countries: 0. Publications: 0.
Lifting Effect on Recovery After Mastectomy
ClinicalTrials.gov study NCT05178329. IPD Sharing: NO. Countries: 0. Publications: 0.
Dataset related to article "Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment "
<p>This record contains raw data related to article "Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment"</p><p>Abstract</p><p><strong>Background: </strong>The initial results of the SINODAR-ONE randomized clinical trial reported that patients with T1-2 breast cancer and one to two macrometastatic sentinel lymph nodes treated with breast-conserving surgery, sentinel lymph node biopsy only, and adjuvant therapy did not present worse 3-year survival, regional recurrence, or distant recurrence rates compared with those treated with axillary lymph node dissection. To extend the recommendation of axillary lymph node dissection omission even in patients treated with mastectomy, a sub-analysis of the SINODAR-ONE trial is presented here.</p><p><strong>Methods: </strong>Patients with T1-2 breast cancer and no more than two metastatic sentinel lymph nodes undergoing mastectomy were analysed. After sentinel lymph node biopsy, patients were randomly assigned to receive either axillary lymph node dissection followed by adjuvant treatment (standard arm) or adjuvant treatment alone (experimental arm). The primary endpoint was overall survival. The secondary endpoint was recurrence-free survival.</p><p><strong>Results: </strong>A total of 218 patients were treated with mastectomy; 111 were randomly assigned to the axillary lymph node dissection group and 107 to the sentinel lymph node biopsy-only group. At a median follow-up of 33.0 months, there were three deaths (two deaths in the axillary lymph node dissection group and one death in the sentinel lymph node biopsy-only group). There were five recurrences in each treatment arm. No axillary lymph node recurrence was observed. The 5-year overall survival rates were 97.8 and 98.7 per cent in the axillary lymph node dissection treatment arm and the sentinel lymph node biopsy-only treatment arm, respectively (P = 0.597). The 5-year recurrence-free survival rates were 95.7 and 94.1 per cent in the axillary lymph node dissection treatment arm and the sentinel lymph node biopsy treatment arm, respectively (P = 0.821).</p><p><strong>Conclusion: </strong>In patients with T1-2 breast cancer and one to two macrometastatic sentinel lymph nodes treated with mastectomy, the overall survival and recurrence-free survival rates of patients treated with sentinel lymph node biopsy only were not inferior to those treated with axillary lymph node dissection. To strengthen the conclusion of the trial, the enrolment of patients treated with mastectomy was reopened as a single-arm experimental study.</p><p> </p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.